Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUT | P33316 | 2/20 | 0.36 |
| ▸ | PARP1 | P09874 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.32 |
| ▸ | APLNR | P35414 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25356197 | 1.00 | DUT (0.36) | DUTPARP1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL8226277 | 0.82 | CYP1A2 (0.38) | PARP1CYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL29682062 | 0.80 | DUT (0.32) | DUTAPLNR | |
| SCHEMBL24206569 | 0.80 | DUT (0.32) | DUTAPLNR | |
| SCHEMBL410888 | 0.79 | DUT (0.40) | DUTKDM4EIDO1ALDH1A1 | |
| SCHEMBL3643273 | 0.77 | TAAR1 (0.44) | DUTMAOBIDO1 | |
| SCHEMBL25356793 | 0.77 | PARP1 (0.39) | DUTPARP1PARP2 | |
| SCHEMBL30531078 | 0.77 | PARP1 (0.39) | DUTPARP1PARP2 | |
| SCHEMBL30859481 | 0.76 | DUT (0.40) | DUTIDO1ALDH1A1 | |
| SCHEMBL20521475 | 0.76 | DUT (0.34) | DUTKDM4EMAOBIDO1APLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4476230-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | Vertex Pharmaceuticals Incorporated (US) | 2024-12-18 | — | — | EP | disclosed |
| WO-2023154291-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2023-08-17 | — | — | WO | disclosed |